Pergolide Mesylate 0.2 mg/ml Oral Liquid is a specially compounded medication designed for oral use, providing a precise 0.2 mg of pergolide mesylate per milliliter of liquid. This formulation is particularly beneficial for patients who have difficulty swallowing pills, such as those in pediatric or geriatric populations, or for individuals with conditions that impair their ability to ingest solid dosage forms. The liquid form allows for flexible dosing, which can be easily adjusted according to the specific needs of the patient.

Pergolide mesylate is a dopamine agonist that mimics the action of dopamine in the brain. It is primarily used in the treatment of Parkinson's disease, a neurodegenerative disorder characterized by tremors, stiffness, and bradykinesia (slowness of movement). By stimulating dopamine receptors, pergolide helps to alleviate the motor symptoms associated with the disease, improving the quality of life for those affected. Additionally, pergolide mesylate has been used off-label for the treatment of hyperprolactinemia, a condition where there is an excess of prolactin in the blood, often leading to various symptoms including infertility and bone loss.

It is important for both patients and prescribers to be aware that pergolide mesylate can have side effects, including nausea, dizziness, and orthostatic hypotension, among others. Regular monitoring and dose adjustments may be necessary to minimize these effects. Furthermore, due to the potential for serious heart valve damage, the use of pergolide mesylate should be carefully considered and regularly evaluated by a healthcare professional. Patients should be counseled on the importance of adhering to their prescribed dosing schedule and to report any adverse effects or concerns to their healthcare provider promptly.

At Bayview Pharmacy, we are committed to providing high-quality, customized medications to meet the unique needs of our patients. Our team of expert compounding pharmacists is available to answer any questions and provide guidance on the use of Pergolide Mesylate 0.2 mg/ml Oral Liquid. If you have any questions or require further information about this formulation, please do not hesitate to reach out to us.

Pergolide mesylate is a dopamine agonist that is used primarily to treat Parkinson's disease by mimicking the action of dopamine in the brain, which is typically low in individuals with this condition. It can also be used for other conditions as determined by a healthcare provider. When considering the use of pergolide mesylate 0.2 mg/ml oral liquid, it is important to be aware of potential drug interactions that could affect the efficacy of the medication or increase the risk of adverse effects.

One significant interaction is with anti-psychotic medications, such as phenothiazines, butyrophenones, thioxanthenes, or metoclopramide, which can diminish the effectiveness of pergolide by blocking dopamine receptors. Patients taking these medications should consult their healthcare provider before starting pergolide. Additionally, caution is advised when pergolide is co-administered with other central nervous system (CNS) depressants, including alcohol, benzodiazepines, and opioids, as these can exacerbate CNS depression and lead to increased drowsiness or dizziness.

Medications that inhibit CYP3A4, an enzyme responsible for the metabolism of pergolide, such as erythromycin, clarithromycin, and azole antifungals (e.g., ketoconazole, itraconazole), can increase pergolide levels in the blood and may necessitate dosage adjustments. Conversely, CYP3A4 inducers like rifampin, carbamazepine, and phenytoin can decrease pergolide levels and reduce its effectiveness. Blood pressure-lowering medications may have their effects potentiated by pergolide, leading to an increased risk of hypotension, so careful monitoring of blood pressure is recommended when these drugs are used concurrently.

Patients should also be aware that pergolide can interact with other dopamine agonists or antagonists, as these can either enhance or counteract the therapeutic effects of pergolide. Additionally, since pergolide can cause drowsiness, patients should be cautious when taking other medications that can cause sedation, such as antihistamines or sleep medications.

It is crucial for patients to inform their healthcare provider of all medications, supplements, and over-the-counter drugs they are currently taking before starting treatment with pergolide mesylate oral liquid. This will help to identify any potential interactions and allow for proper management. If you have any questions or concerns about drug interactions with pergolide mesylate, please reach out to us at Bayview Pharmacy for further assistance.

Pergolide mesylate is a dopamine agonist that mimics the action of dopamine in the brain. It is particularly effective in the treatment of Parkinson's disease, a neurological disorder characterized by a deficiency of dopamine, leading to symptoms such as tremors, muscle stiffness, and impaired movement. Pergolide mesylate works by stimulating dopamine receptors in the brain, which helps to improve these symptoms. The efficacy of pergolide in treating Parkinson's disease has been well-documented, and it has been a valuable therapeutic option for patients who may not respond adequately to other treatments.

The 0.2 mg/ml oral liquid formulation of pergolide mesylate provides a precise dosage that can be easily adjusted to meet the individual needs of patients. This is particularly beneficial for those who require a tailored approach to their medication regimen, such as patients with fluctuating symptoms or those who experience side effects at higher doses. The liquid form is also advantageous for patients who have difficulty swallowing pills, such as the elderly or those with dysphagia. Additionally, the oral liquid can be more palatable and easier to administer to pediatric patients who may be resistant to taking solid dosage forms.

When administered, the pergolide mesylate oral liquid is absorbed through the gastrointestinal tract and enters the bloodstream, where it is transported to the brain. Once in the brain, it crosses the blood-brain barrier and binds to dopamine receptors, particularly D2 receptors, which are involved in motor control. By activating these receptors, pergolide mesylate helps to restore the balance of dopamine and improve motor function in patients with Parkinson's disease. It may also be used in the treatment of other conditions where dopamine agonist therapy is indicated, such as restless legs syndrome or pituitary gland tumors producing prolactin.

It is important for patients and prescribers to understand that while pergolide mesylate can significantly improve symptoms, it does not cure Parkinson's disease or other related disorders. Long-term management and regular monitoring by a healthcare professional are essential to optimize treatment outcomes and manage any potential side effects. Patients should also be aware that abrupt discontinuation of the medication can lead to withdrawal symptoms and a rapid return of disease symptoms, so any changes to the medication regimen should be made under the guidance of a healthcare provider.

For more detailed information on the use of pergolide mesylate 0.2 mg/ml oral liquid, or if you have any questions regarding this formulation, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing comprehensive support and guidance to both patients and prescribers to ensure the safe and effective use of this medication.

Pergolide mesylate is a medication primarily indicated for the treatment of Parkinson's disease, working by stimulating dopamine receptors in the brain, thereby improving symptoms such as tremors, stiffness, and slowness of movement. The strength of 0.2 mg/ml in an oral liquid formulation provides flexibility in dosing, particularly beneficial for patients requiring individualized dosing adjustments for optimum therapeutic effect.

Although the primary use of pergolide mesylate is for Parkinson's disease, it has also been used off-label to manage other conditions. For instance, some clinicians have explored its utility in treating restless legs syndrome (RLS), a disorder characterized by an irresistible urge to move the legs, typically accompanied by uncomfortable sensations. The dopaminergic effect of pergolide may provide symptomatic relief in RLS, much like its effect on Parkinson's. Furthermore, studies have looked at pergolide's efficacy in treating hyperprolactinemia, which is an elevated level of prolactin in the blood, typically resulting in menstrual disorders in women and decreased sexual drive in men. Pergolide, through its inhibitory action on prolactin secretion, may be beneficial in these cases.

With its liquid form, the medication is also a valuable option for patients who have difficulty swallowing pills or tablets, such as those with dysphagia, which can occur in various neurological disorders, including Parkinson's disease. Pediatric and geriatric patients, who may also have issues with solid dosage forms, can find the liquid formulation easier to administer. In addition, the liquid format allows for titration to the lowest effective dose with the potential for minimizing side effects, which can be particularly useful in sensitive populations or when initiating therapy.

It is important to note that while there may be other uses for pergolide mesylate beyond those officially approved, such use should only be considered when the benefits outweigh the risks and under the supervision of a healthcare professional. Long-term use of pergolide has been associated with an increased risk of heart valve damage, so careful monitoring is necessary. Physicians considering the off-label use of pergolide mesylate should thoroughly evaluate the patient's clinical condition and review the latest medical literature to ensure an evidence-based approach to treatment.

Patients and prescribers must also be aware that this formulation must be compounded by a qualified pharmacist and it is not commercially available in this specific concentration and form. At Bayview Pharmacy, our compounding pharmacists possess the expertise necessary to prepare this specialized formulation and can offer guidance regarding its use. If you have any questions or need further information on pergolide mesylate 0.2 mg/ml oral liquid or its other potential uses, please reach out to us. We're here to ensure that your medication needs are met with the highest standards of personalized care.